• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

AACR In New Partnership For San Antonio Breast Cancer Symposium

  • — 14 Dec, 2007
AudioMedica News
AudioMedica News
AACR In New Partnership For San Antonio Breast Cancer Symposium
AACR In New Partnership For San Antonio Breast Cancer Symposium
00:00 /
RSS Feed
Share
Link
Embed
Margaret Foti
Margaret Foti

MARGARET FOTI, American Association for Cancer Research, Philadelphia
The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer Therapy and Research Center at the University of Texas Health Science Center, Baylor College of Medicine, and the American Association for Cancer Research. Peter Goodwin found out more on this new collaboration from Margaret Foti, CEO of the American Association for Cancer Research in Philadelphia.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/071213_margeret_foti.mp3]

You may also like...

  • Mathias Rummel Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab 7 Jun, 2012
  • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen. Paracetamol use during pregnancy might put babies at risk of ADHD 28 Feb, 2014
  • Ultrahypofractionated Radiation Just As Effective for Prostate Cancer Ultrahypofractionated Radiation Just As Effective for Prostate Cancer 16 May, 2018
  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer 16 Mar, 2008
  • Previous story Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
  • Next story New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
  • Home
  • News
  • AACR In New Partnership For San Antonio Breast Cancer Symposium

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.